NexGel, Inc. NXGL 深 沪
交易中 04-01 10:53:15 美东时间
0.66
+0.027
+4.27%
华盛通- 最 高0.6609
- 今 开0.63
- 成交量 2.07万股
- 最 低 0.61
- 昨 收 0.633
- 总市值 537.45万
- 52周最高 3.0191
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.5772
- 委 比 -78.57%
- 总股本 814.31万
- 历史最高 5.10
- 量 比 1.29
- 振 幅 8.04%
- 历史最低 0.5772
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NexGel Q4 EPS $(0.12) Misses $(0.09) Estimate, Sales $2.796M Miss $3.240M Estimate
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from the same
今天 05:34
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
Nexgel updates its financial calendar; management hosts a conference call at 4:30 P.M. ET
Nexgel updates its financial calendar; management hosts a conference call at 4:30 P.M. ET NEXGEL will report financial results for the fourth quarter and full year ended December 31, 2025 after the market close on March 31, 2026. Management will host a conference call at 4:30 P.M. ET on March 31, 20
03-25 21:04
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st
NEXGEL, Inc., a leading provider of healthcare, beauty, and OTC products, including hydrogel products, announced it will report its fourth-quarter and full-year 2025 financial results on March 31, 2026, after market close. The company will host a conference call at 4:30 P.M. ET on the same day. The call can be accessed via phone or webcast, with information provided for dial-in numbers and a live webcast link. A replay will be available until Apr...
03-25 13:00
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular s...
03-21 01:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 23.3% to $0.16 during Tues...
03-11 05:06
Celularity Licenses Biomaterials Portfolio to NexGel Partner
The latest update is out from Celularity ( ($CELU) ). On March 6, 2026, Celular...
03-10 21:35
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue
NexGel to acquire Celularity biomaterial products, a deal expected to triple revenue to $35 million and make the company profitable.
03-10 20:30
Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
ZVRA up in pre-market trading on better-than-expected Q4 results. Gainers include BRTX, COOT, BIYA, SOAR, MTEN, MDCX, NXGL, ABTC, and VALN. Losers include GSIW, POM, ARQ, RAIL, and NTZ.
03-10 16:42
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
NEXGEL, Inc. has signed a definitive agreement to license and acquire a portfolio of commercial-stage regenerative biomaterial products from Celularity Inc., expected to triple NEXGEL’s annual revenue to approximately $35 million and make the company immediately profitable. The transaction includes six established regenerative biomaterial products with existing insurance reimbursement, three new product 510(k) filings planned for 2026-2028, and t...
03-10 12:45
